معرفی
Boris Kysela is a Senior Lecturer in Human Molecular Genetics at the Aston Medical School, part of the Translational Medicine Research Group (TMRG) within the College of Health and Life Sciences at Aston University. He holds an honorary position as Senior Lecturer at the University of Birmingham.
Education: PhD in Ionizing Radiation-Induced DNA Damage and Repair (Brunel University, 1994) and MSc in Microbiology, Genetics, and Biophysics (Univerzita Karlova, 1985). His research focuses on DNA repair mechanisms, neuro-regeneration strategies, and nanotechnology applications in cancer therapy. Key areas include manipulating DNA damage responses to promote CNS repair and developing targeted nanoparticles for drug delivery.
Research interests span translational medicine, chromatin structure effects on DNA repair, and the commercialization of therapeutic platforms. He has secured over £1.27 million in grants, including funding from the MRC, BBSRC, and international bodies. His work combines basic science with clinical translation, addressing neurodegenerative diseases and cancer treatment.
Professional roles include membership on grant review committees (e.g., EU Synchrotron Radiation Facility, Slovak Republic Proton Therapy) and editorial roles for journals like Journal of Biological Chemistry and Nucleic Acid Research. He has presented keynote lectures at major conferences, including the International Conference on Brain and Neurological Disorders (2018) and the World Congress of Nanoscience (2017).
His research group collaborates with institutions globally, advancing therapies for neurodegeneration and cancer through innovative nanoparticle designs and DNA repair modulation strategies.
